Suncorp Group Limited (ASX: SUN) intends to hold Extraordinary General Meeting, seeking for the approval of shareholders in respect of pro-rata return of capital and share consolidation on the sale of its Australian life insurance business. The meeting is due to be held on 13 December 2018.
On the receipt of due approvals from company’s shareholders and the respective regulatory authorities, Suncorp Group will return ~$600 million of capital as per its capital management initiative. The action is said to be supported by the sale proceeds of $725 million which is due to be received on the completion of sale transaction of Australian life insurance business with TAL Dai-ichi Life Australia Pty Ltd (TAL).
“Allowing for separation and transaction costs, provisions and hybrid capital, Suncorp anticipates returning approximately $600 million to shareholders following the completion of the Transaction” the company stated earlier.
On 9 August 2018, insurer Suncorp Group Limited first announced that it entered into a non-binding agreement to sell its Australian life insurance business to Japanese insurance group’s subsidiary TAL Dai-ichi Life Australia Pty Ltd (TAL) for the total consideration of approximately $725 million. Subsequently on 4 September 2018, the company announced the execution of share sale deed which included a 20-year distribution agreement with TAL.
Under the terms of agreement, the market-leading life insurance solutions will be offered jointly by Suncorp Group and TAL Dai-ichi through Suncorp’s Australian digital channels, contact centers, store network and other distribution channels. However, it has been told that post alliance Suncorp will continue to earn income on the distribution of life insurance.
TAL Dai-ichi Life Australia Pty Ltd (TAL) is a subsidiary of Japanese life insurance group Dai-ichi Life Holdings. TAL operates within Australia as a life insurance specialist which offers insurance through direct to customer channels, through a financial adviser and via group and workplace superannuation schemes.
The notice of EGM which is scheduled to be held on 13 December 2018, is intended to be sent to SUN’s shareholders in early November 2018. However, the sale transaction is expected to be completed by 31 December 2018, subject to completion of certain conditions and regulatory approvals in Australia and Japan.
The share price of Suncorp group Limited edged up by 1.271% to $14.340 on 4 October 2018 (4:06 PM AEST). In the past one year the stock of insurer Suncorp group has shown a performance growth of 9.15% while it has gone down by 2.31% in the last 3-month period. SUN most recently traded at a PE of 17.230 x with market capitalization of $18.39 billion.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a company’s prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.